Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press50010.36691/RJA500ArticlesСтатьиResearch ArticleLONG-TERM CONTROL OF SKIN ALLERGIC INFLAMMATION IN ATOPIC DERMATITIS PATIENTSДЛИТЕЛЬНЫЙ КОНТРОЛЬ АЛЛЕРГИЧЕСКОГО ВОСПАЛЕНИЯ КОЖИ У БОЛЬНЫХ АТОПИЧЕСКИМ ДЕРМАТИТОМELISYUTINAO GЕЛИСЮТИНАОльга Гурьевнаel-olga@yandex.ruFEDENKOE SФЕДЕНКОЕ СInstitute of ImmunologyФГБУ «ГНЦ институт иммунологии» ФМБА Россииru150620142014113NO3 (2014)№3 (2014)303610032020Received:10032020Published:15062014Copyright ©; 2014, Pharmarus Print MediaCopyright ©; 2014, Фармарус Принт Медиа2014Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/500

Modern approaches to topical treatment of atopic dermatitis (ad) are presented in the review. the application of different proactive therapy patterns like topical corticosteroids intermittent treatment and topical calcineurin inhibitors as antirecurrent therapy of ad patients are discussed.

В статье представлены литературные данные о современных подходах к лечению атопического дерма тита с применением схем проактивной терапии: интермиттирующей наружной терапии топическими глюкокортикостероидами и противорецидивной терапии топическими ингибиторами кальциневрина.

atopic dermatitistacrolimuscalcineurin inhibitorstopical corticosteroidsproactive therapyатопический дерматиттакролимусингибиторы кальциневринатопические глюкокортикостероидыпроактивная терапияАллергология и иммунология: национальное руководство. Под ред. Р.М. Хаитова, Н.И. Ильиной. М., «ГЭОТАР- Медиа». 2009, 656 с.Darsow U., Wollenberg A., Simon D. et al. European Task Force on Atopic Dermatitis EADV Eczema Task Force. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J. Eur. Acad. Dermatol Venereol. 2010, v. 24, p. 317-328.Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part. I. J. Eur. Acad. Dermatol Venereol. 2012, v. 26, p. 1045-1060.Ring J., Alomar A., Bieber T. et al. Guidelines for treatment of atopic eczema (atopic dermatitis). Part II. J. Eur. Acad. Dermatol Venereol. 2012, v. 26, p. 1176-1093.Proksch E., Fölster-Holst R., Jensen J.M. Skin barrier func- tion, epidermal proliferation and differentiation in eczema. J. Dermatol Sci. 2006, v. 43, p. 159-169.Wollenberg A., Bieber T. Proactive therapy of atopic dermati- tis - anemerging concept. Allergy. 2009, v. 64, p. 276-278.Spergel J.M. Immunology and treatment of atopic dermatitis. Am. J. Clin. Dermatol. 2008, v. 9, p. 233-244.Cork M.J., Robinson D.A., Vasilopoulos Y. et al. New per- spectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J. Allergy Clin. Immunol. 2006, v. 118, p. 3-21.Werner Y., Lindberg M. Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm. Venereol. 1985, v. 65, p. 102-105.Van Der Meer J.B., Glazenburg E.J., Mulder P.G. et al. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br. J. Dermatol. 1999, v. 140, p. 1114-1121.Wollenberg A., Frank R., Kroth J., Ruzicka T. Proactive therapy of atopic eczema-an evidence-based concept with a behavioral background. J. Dtsch. Dermatol Ges. 2009, v. 7, p. 117-121.Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacology & Thera- peutics. 2002, v. 96, p. 23-43.Hengge U.R., Ruzicka T., Schwartz T.A. et al. Adverse effects of topical glucocorticosteroids. J. Am. Acad. Dermatol. 2006, v. 54, p. 1-15.Hanifin J., Gupta A.K., Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br. J. Dermatol. 2002, v. 147, p. 528-537.Peserico A., Städtler G., Sebastian M. et al. Reduction of re- lapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br. J. Dermatol. 2008, v. 158, p. 801-807.Veien N.K., Olholm Larsen P., Thestrup-Pedersen K. et al. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate. Br. J. Dermatol. 1999 v. 140, p. 882-886.Faergemann J., Christensen O., Sjövall P. et al. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2000, v. 14, p.393-396.Liu J., Farmer J.D.Jr., Lane W.S. et al. Calcineurin is a com- mon target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991, v. 66, p. 807-815.Wollenberg A., Reitamo S., Girolomoni G. et al. European Tacrolimus Ointment Study Group. Proactive treatment of atopic dermatitis in adults with 0,1% tacrolimus ointment. Allergy. 2008, v. 63, p. 742-750.Thaçi D., Reitamo S., Gonzalez Ensenat M.A. et al. European Tacrolimus Ointment Study Group. Proactive disease manage- ment with 0,03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br. J. Dermatol. 2008, v. 159, p. 1348-1356.Reitamo S. Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies. Journal of Dermatological Treatment. 2010, v. 21, p. 34-44.Елисютина О.Г., Феденко Е.С., Штырбул О.В. Применение такролимуса у больных атопическим дерматитом с осложнениями вследствие длительного использования топических глюкокортикостероидов. Клинические слу- чаи. Рос. Аллергол. Журн. 2012, № 6, с. 32-38.